Dong Aling, Ye Min, Guo Hongzhu, Zheng Junhua, Guo Dean
The State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Xueyuan Road #38, Beijing 100083, PR China.
Biotechnol Lett. 2003 Feb;25(4):339-44. doi: 10.1023/a:1022320824000.
Of 49 microbial strains screened for their capabilities to transform ginsenoside Rb1, Rhizopus stolonifer and Curvularia lunata produced four key metabolites: 3-O-[beta-D-glucopyranosyl-(1,2)-beta-D-glucopyranosyl]-20-O-[beta-D-glucopyranosyl]-3beta,12beta, 20(S)-trihydroxydammar-24-ene (1), 3-O-[beta-D-glucopyranosyl-(1,2)-beta-D-glucopyranosyl]-20-O-[beta-D-glucopyranosyl]-3beta,12beta, 20(S)-trihydroxydammar-24-ol (2), 3-O-[beta-D-glucopyranosyl-(1,2)-beta-D-glucopyranosyl]-3beta, 12beta, 20(S)-trihydroxydammar-24-ene (3), and 3-O-beta-D-glucopyranosyl-3beta, 12beta, 20(S)-trihydroxydammar-24-ene (4), identified by TOF-MS, 1H- and 13C-NMR spectral data. Metabolites 1, 3 and 4 were from the incubation with R. stolonifer, and 1 and 2 from the incubation with C. lunata. Compound 2 was identified as a new compound.
在筛选的49种具有转化人参皂苷Rb1能力的微生物菌株中,匍枝根霉和新月弯孢霉产生了四种关键代谢产物:3-O-[β-D-吡喃葡萄糖基-(1,2)-β-D-吡喃葡萄糖基]-20-O-[β-D-吡喃葡萄糖基]-3β,12β,20(S)-三羟基达玛-24-烯(1)、3-O-[β-D-吡喃葡萄糖基-(1,2)-β-D-吡喃葡萄糖基]-20-O-[β-D-吡喃葡萄糖基]-3β,12β,20(S)-三羟基达玛-24-醇(2)、3-O-[β-D-吡喃葡萄糖基-(1,2)-β-D-吡喃葡萄糖基]-3β,12β,20(S)-三羟基达玛-24-烯(3)和3-O-β-D-吡喃葡萄糖基-3β,12β,20(S)-三羟基达玛-24-烯(4),通过飞行时间质谱、1H和13C核磁共振光谱数据鉴定。代谢产物1、3和4来自与匍枝根霉的培养,1和2来自与新月弯孢霉的培养。化合物2被鉴定为一种新化合物。